Alzheimer's beginnings prove to be a sticky situation

September 12, 2016 by Layne Cameron , Lisa Lapidus
MSU's Lisa Lapidus uses lasers to reveal a common trait of Alzheimer's beginnings. Credit: G.L. Kohuth

Laser technology has revealed a common trait of Alzheimer's disease - a sticky situation that could lead to new targets for medicinal treatments.

Alzheimer's statistics are always staggering. The neurodegenerative disease affects an estimated 5 million Americans, one in three seniors dies with Alzheimer's or a form of dementia, it claims more lives than breast and prostate cancers combined, and its incidence is rising.

To help fight this deadly disease, Lisa Lapidus, Michigan State University professor of physics and astronomy, has found that peptides, or strings of amino acids, related to Alzheimer's wiggle at dangerous speeds prior to clumping or forming the plaques commonly associated with Alzheimer's.

"Strings of 40 amino acids are the ones most-commonly found in healthy individuals, but strings of 42 are much more likely to clump," said Lapidus, who published the results in the current issue of ChemPhysChem. "We found that the peptides' wiggle speeds, the step before , was five times slower for the longer strings, which leaves plenty of time to stick together rather than wiggle out of the way."

This so-called "wiggle" precedes clumping, or aggregating, which is the first step of neurological disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease. Lapidus pioneered the use of lasers to study the speed of protein reconfiguration before aggregation.

If reconfiguration is much faster or slower than the speed at which proteins bump into each other, aggregation is slow. If reconfiguration is the same speed, however, aggregation is fast. She calls the telltale wiggle that she discovered the "dangerous middle."

"The dangerous middle is the speed in which clumping happens fastest," Lapidus said. "But we were able to identify some ways that we can bump that speed into a safer zone."

Lapidus and her team of MSU scientists, including Srabasti Acharya, Kinshuk Srivastava and Sureshbabu Nagarajan, found that increasing pH levels kept the amino acids wiggling at fast, safe speeds. Also, a naturally occurring molecule, curcumin (from the spice turmeric), kept the peptide out of the dangerous middle.

While this is not a viable drug candidate because it does not easily cross the blood-brain barrier, the filter that controls what chemicals reach the brain, they do provide strong leads that could lead to medicinal breakthroughs.

Along with new drug targets, Lapidus' research provides a potential model of early detection. By the time patients show symptoms and go to a doctor, aggregation already has a stronghold in their brains. Policing for wiggling at dangerous speeds could tip off doctors long before the patient begins to suffer from the .

Explore further: Physicists push new Parkinson's treatment toward clinical trials

Related Stories

Physicists push new Parkinson's treatment toward clinical trials

April 21, 2014
The most effective way to tackle debilitating diseases is to punch them at the start and keep them from growing. Research at Michigan State University, published in the Journal of Biological Chemistry, shows that a small ...

Curcumin shows promise in attacking Parkinson's disease

March 20, 2012
Curcumin, a compound found in the spice turmeric, is proving effective at preventing clumping of a protein involved in Parkinson's disease, says a Michigan State University researcher.

Researchers identify path to treat Parkinson's disease at its inception

January 16, 2012
(Medical Xpress) -- Imagine if doctors could spot Parkinson’s disease at its inception and treat the protein that triggers it before the disease can sicken the patient.   A team of researchers led by Basir Ahmad, ...

Gene signature in healthy brains pinpoints the origins of Alzheimer's disease

August 10, 2016
Researchers have discovered a gene signature in healthy brains that echoes the pattern in which Alzheimer's disease spreads through the brain much later in life. The findings, published in the journal Science Advances, could ...

Diagnosing Alzheimer's earlier rather than later

May 9, 2016
A hallmark of Alzheimer's disease is the appearance of plaques in the brain. The plaques are gradually made up by the aggregation of a small protein called amyloid-beta or "Abeta". Alzheimer's is usually diagnosed late, when ...

Recommended for you

Thinking 'out-of-the-box' may build a better brain and prevent dementia

September 25, 2017
More than 5 million Americans today are affected by Alzheimer's disease (AD). If nothing is done to stop this upward trajectory, there will be more than 16 million people with AD in the United States and more than 60 million ...

Multi-gene test predicts Alzheimer's better than APOE E4 alone

September 22, 2017
A new test that combines the effects of more than two dozen genetic variants, most associated by themselves with only a small risk of Alzheimer's disease, does a better job of predicting which cognitively normal older adults ...

Personality changes don't precede clinical onset of Alzheimer's, study shows

September 21, 2017
For years, scientists and physicians have been debating whether personality and behavior changes might appear prior to the onset of Alzheimer's disease and related dementias.

Newly ID'd role of major Alzheimer's gene suggests possible therapeutic target

September 20, 2017
Nearly a quarter century ago, a genetic variant known as ApoE4 was identified as a major risk factor for Alzheimer's disease—one that increases a person's chances of developing the neurodegenerative disease by up to 12 ...

Is the Alzheimer's gene the ring leader or the sidekick?

September 15, 2017
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.

Potential noninvasive test for Alzheimer's disease

September 6, 2017
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.